Home › Parkinson's Disease › Kentucky
Parkinson's Disease clinical trials in Kentucky
9 studies for Parkinson's Disease are looking for participants at sites in Kentucky.
Cities in Kentucky
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Kentucky, Lexington
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Kentucky Neuroscience Institute (Site #213), Lexington
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Kentucky, Lexington
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
- University of Kentucky, Lexington
RecruitingPhase 1
Ages 40 to 75 · All sexes · Updated Aug 31, 2026 · NCT06683365A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery
- University of Kentucky, Lexington
RecruitingPhase 1
Ages 45 to 75 · All sexes · Updated Aug 31, 2026 · NCT06683378A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Louisville Hospital, Louisville
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522Spinal Cord Stimulation for Parkinson's Disease Rehabilitation
- Frazier Rehab Institute, Louisville
Recruiting
Ages 18 to 80 · All sexes · Updated Mar 11, 2026 · NCT06804642A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- University of Kentucky Medical Center, Lexington
RecruitingPhase 1/2
Ages 40 to 72 · All sexes · Updated Mar 2, 2026 · NCT06753331Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- University of Louisville, Louisville
RecruitingObservational study
All ages · All sexes · Updated Jan 8, 2026 · NCT04071847From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.